When Novelty is Not Enough:
Creating value early and throughout the clinical development process
Dr. Michael Murphy, MD, PhD
Chief Medical and Scientific Officer - Worldwide Clinical Trials
Henry Riordan, PhD - Executive Vice President, CNS Franchise Lead
Andrew Moniz, MS - Vice President, Global CNS Operations
Jeffrey Weisberg, DO, FACP - Vice President, Medical and Scientific Affairs, Oncology
Jeffrey Miller, MS - Senior Director, Project Management & Clinical Operations, Oncology
Join your Bay Area colleagues in a discussion regarding building value early and throughout development of an asset or pipeline.
If you are unable to attend the breakfast seminar, please click here for information on our lunch seminar in South San Francisco.
For more information please email Judy Wudel (Judith.Wudel@wwctrials.com).
When & Where
Worldwide Clinical Trials
Worldwide Clinical Trials is a global CRO providing full-service drug development services to the biopharmaceutical industry from Early Phase and Bioanalytical Sciences through Phase II and III trials to Peri-Approval studies. We believe successful drug development strategically balances science, medicine, operations and commercial intelligence. Our mission is to foster the development of life changing medicines by integrating clinical methodology, operational acumen and efficient technology.